Mizoribine Suppresses the Progression of Experimental Peritoneal Fibrosis in a Rat Model | Zendy

Shunsuke Takahashi | Zendy; Yoshihiko Taniguchi | Zendy; Ayumu Nakashima | Zendy; Tetsuji Arakawa | Zendy; Tōru Kawai | Zendy; Shigehiro Doi | Zendy; Takafumi Ito | Zendy; Takao Masaki | Zendy; Nobuoki Kohno | Zendy; Noriaki Yorioka | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mizoribine Suppresses the Progression of Experimental Peritoneal Fibrosis in a Rat Model

Author(s) -

Shunsuke Takahashi,

Yoshihiko Taniguchi,

Ayumu Nakashima,

Tetsuji Arakawa,

Tōru Kawai,

Shigehiro Doi,

Takafumi Ito,

Takao Masaki,

Nobuoki Kohno,

Noriaki Yorioka

Publication year - 2009

Publication title -

nephron experimental nephrology

Language(s) - English

Resource type - Journals

ISSN - 1660-2129

DOI - 10.1159/000213896

Subject(s) - mizoribine , peritoneal dialysis , fibrosis , medicine , cd163 , infiltration (hvac) , saline , peritoneum , pharmacology , pathology , chemistry , macrophage , physics , biochemistry , in vitro , thermodynamics

Peritoneal fibrosis is a serious complication of peritoneal dialysis (PD). It has been reported that administration of mizoribine, an effective immunosuppressant, ameliorated renal fibrosis in a rat model of unilateral ureteral obstruction. We therefore examined the effects of mizoribine in an experimental model of peritoneal fibrosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research